SYNALAR DIN 02162504
Health Canada record
| Active ingredient(s) | FLUOCINOLONE ACETONIDE 0.01 % |
|---|---|
| Dosage form | Solution |
| Route | Topical |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | D07AC04 FLUOCINOLONE ACETONIDE |
| Original market date | 31-Dec-1996 |
| Current status date | 06-May-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bausch Health Companies Inc. — licence 101880, currently licensed, last inspection rating C (2026-06-01).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLUOCINOLONE ACETONIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00873292 | DERMA SMOOTHE/FS LIQ 0.01% | HILL DERMACEUTICALS INC | Emulsion | FLUOCINOLONE ACETONIDE 0.01 % | Marketed |
| 02300559 | DERMOTIC OIL EAR DROPS | HILL DERMACEUTICALS INC | Solution | FLUOCINOLONE ACETONIDE 0.01 % | Marketed |
| 02242738 | CAPEX | GALDERMA CANADA INC. | Shampoo | FLUOCINOLONE ACETONIDE 0.01 % | Cancelled Post Market |
| 00716812 | FLUODERM ONT 0.025% | TARO PHARMACEUTICALS INC | Ointment | FLUOCINOLONE ACETONIDE 0.25 MG | Cancelled Post Market |
| 02483157 | ILUVIEN | KNIGHT THERAPEUTICS INC. | Implant | FLUOCINOLONE ACETONIDE 0.19 MG | Cancelled Pre Market |
| 02306980 | RETISERT | BAUSCH & LOMB INC | Implant | FLUOCINOLONE ACETONIDE 0.59 MG | Dormant |
| 02162512 | SYNALAR | BAUSCH HEALTH, CANADA INC. | Ointment | FLUOCINOLONE ACETONIDE 0.025 % | Dormant |
| 00189499 | SYNALAR BI-OTIC SOLUTION | MEDICIS CANADA LTD. | Solution | FLUOCINOLONE ACETONIDE 0.25 MG; NEOMYCIN (NEOMYCIN SULFATE) 3.5 MG; POLYMYXIN B SULFATE 10000 UNIT | Cancelled Post Market |
| 00030422 | SYNALAR CREAM 0.025% | MEDICIS CANADA LTD. | Cream | FLUOCINOLONE ACETONIDE 0.025 % | Cancelled Post Market |
| 00030414 | SYNALAR CREAM MILD 0.01% | MEDICIS CANADA LTD. | Cream | FLUOCINOLONE ACETONIDE 0.01 % | Cancelled Post Market |
| 00030392 | SYNALAR OINTMENT MILD 0.01% | MEDICIS CANADA LTD. | Ointment | FLUOCINOLONE ACETONIDE 0.01 % | Cancelled Post Market |
| 00424927 | SYNAMOL MILD 0.01% CREAM | MEDICIS CANADA LTD. | Cream | FLUOCINOLONE ACETONIDE 0.01 % | Cancelled Post Market |
| 00424935 | SYNAMOL REGULAR 0.025% CREAM | MEDICIS CANADA LTD. | Cream | FLUOCINOLONE ACETONIDE 0.025 % | Cancelled Post Market |
| 02237340 | SYNOTIC | ZOETIS CANADA INC | Solution | FLUOCINOLONE ACETONIDE 0.01 %; DIMETHYL SULFOXIDE 60 % | Cancelled Post Market |
| 00507229 | SYNOTIC OTIC SOLUTION | SYNTEX ANIMAL HEALTH, DIVISION OF SYNTEX INC. | Solution | FLUOCINOLONE ACETONIDE 0.01 %; DIMETHYL SULFOXIDE 60 % | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 24405 | 2020-10-08 | New Drug Submission (NDS) | CHANGE IN PRODUCT OWNERSHIP |
| 16310 | 2014-11-17 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 10292 | 2009-06-24 | New Drug Submission (NDS) | Manufacturer name change |
| 5025 | 1995-04-18 | New Drug Submission (NDS) |
International API supply for FLUOCINOLONE ACETONIDE
2 valid EDQM Certificates of Suitability from 2 holders. 4 active FDA Drug Master Files.
Request a quote for SYNALAR